Invesco’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-17,561
| Closed | -$2.08M | – | 4128 |
|
|
2021
Q1 | $2.08M | Buy |
17,561
+91
| +0.5% | +$10.8K | ﹤0.01% | 2761 |
|
|
2020
Q4 | $2.06M | Sell |
17,470
-33,270
| -66% | -$3.86M | ﹤0.01% | 2617 |
|
|
2020
Q3 | $5.64M | Buy |
50,740
+1,542
| +3% | +$166K | ﹤0.01% | 1951 |
|
|
2020
Q2 | $5.03M | Buy |
49,198
+12,577
| +34% | +$1.35M | ﹤0.01% | 1986 |
|
|
2020
Q1 | $3.95M | Sell |
36,621
-5,522
| -13% | -$634K | ﹤0.01% | 2019 |
|
|
2019
Q4 | $4.91M | Buy |
42,143
+4,196
| +11% | +$486K | ﹤0.01% | 2180 |
|
|
2019
Q3 | $4.34M | Sell |
37,947
-4,842
| -11% | -$481K | ﹤0.01% | 2207 |
|
|
2019
Q2 | $4.08M | Buy |
42,789
+62
| +0.1% | +$5.84K | ﹤0.01% | 2302 |
|
|
2019
Q1 | $3.9M | Sell |
42,727
-2,196
| -5% | -$180K | ﹤0.01% | 2181 |
|
|
2018
Q4 | $3.41M | Sell |
44,923
-2,305
| -5% | -$170K | ﹤0.01% | 2190 |
|
|
2018
Q3 | $3.78M | Sell |
47,228
-3,484
| -7% | -$325K | ﹤0.01% | 2326 |
|
|
2018
Q2 | $5.04M | Sell |
50,712
-216,489
| -81% | -$18.7M | ﹤0.01% | 2130 |
|
|
2018
Q1 | $21.6M | Sell |
267,201
-936,978
| -78% | -$75.7M | 0.01% | 1123 |
|
|
2017
Q4 | $94.9M | Sell |
1,204,179
-136,377
| -10% | -$11.3M | 0.03% | 512 |
|
|
2017
Q3 | $124M | Buy |
1,340,556
+94,489
| +8% | +$9.08M | 0.05% | 429 |
|
|
2017
Q2 | $141M | Buy |
1,246,067
+13,654
| +1% | +$1.53M | 0.04% | 390 |
|
|
2017
Q1 | $123M | Buy |
1,232,413
+100,578
| +9% | +$10.7M | 0.04% | 434 |
|
|
2016
Q4 | $122M | Buy |
1,131,835
+90,895
| +9% | +$10.6M | 0.04% | 434 |
|
|
2016
Q3 | $130M | Buy |
1,040,940
+70,338
| +7% | +$8.3M | 0.04% | 427 |
|
|
2016
Q2 | $103M | Buy |
970,602
+121,386
| +14% | +$14.1M | 0.04% | 490 |
|
|
2016
Q1 | $97.2M | Buy |
849,216
+795,162
| +1,471% | +$93.3M | 0.04% | 513 |
|
|
2015
Q4 | $7.7M | Buy |
54,054
+7,511
| +16% | +$867K | ﹤0.01% | 1601 |
|
|
2015
Q3 | $4.18M | Buy |
46,543
+68
| +0.1% | +$7.18K | ﹤0.01% | 2001 |
|
|
2015
Q2 | $5.35M | Sell |
46,475
-8,435
| -15% | -$886K | ﹤0.01% | 1935 |
|
|
2015
Q1 | $5.24M | Sell |
54,910
-12,288
| -18% | -$919K | ﹤0.01% | 1938 |
|
|
2014
Q4 | $4.52M | Sell |
67,198
-17,924
| -21% | -$1.11M | ﹤0.01% | 1973 |
|
|
2014
Q3 | $4.59M | Buy |
85,122
+16,816
| +25% | +$828K | ﹤0.01% | 1996 |
|
|
2014
Q2 | $3.04M | Sell |
68,306
-18,790
| -22% | -$768K | ﹤0.01% | 2317 |
|
|
2014
Q1 | $3.03M | Sell |
87,096
-13,241
| -13% | -$422K | ﹤0.01% | 2282 |
|
|
2013
Q4 | $2.9M | Sell |
100,337
-4,736
| -5% | -$137K | ﹤0.01% | 2412 |
|
|
2013
Q3 | $3.07M | Buy |
105,073
+13,660
| +15% | +$340K | ﹤0.01% | 2261 |
|
|
2013
Q2 | $2.12M | Buy |
+91,413
| New | +$2.31M | ﹤0.01% | 2353 |
|
Invesco's CBPO Position: Q2 2021 in Review
Invesco sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 17,561 shares — an estimated $2.08M sold.
Invesco first reported a position in CBPO in Q2 2013 and held it in 32 quarters. The position peaked at $141M in Q2 2017. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Invesco reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Invesco sold 17,561 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2.08M.
- Invesco first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 32 quarters.
- Invesco's China Biologic Products Holdings, Inc. position peaked at $141M in Q2 2017.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.